Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin in neovascular age-related macular degeneration
NCT00347165Phase 2Terminated
- Sponsor
- Asociación para Evitar la Ceguera en México
- Start
- Sep 2005
- Primary completion
- Jun 2006
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in exudative macular degeneration, sponsored by Asociación para Evitar la Ceguera en México. Started Sep 2005; status: terminated.
02
Drugs
bevacizumab
03
Conditions
exudative macular degeneration
Beyond the preview
Go deeper on NCT00347165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00347165.